TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987
TCL Archive Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer February 29, 2008
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
